Back in the early 1990s Professor Andrew Y. Finlay presented the Dermatology Life Quality Index (DLQI), a questionnaire with 10 questions to be used for evaluation of quality of life (QoL) in different skin diseases. The instrument is easy to use in clinical practice and today there are several hundred publications were DLQI has been used. The instrument has also been further developed, e.g. to be used by children and their families. Although there is much focus on QoL and changes/variations in QoL during for example treatment of skin diseases, we are missing a vocabular that is easy to use when describing QoL impairment, in fact we are missing a simple name for it. In this issue of ActaDV Professor Andrew Y. Finlay (1) presents a new word, quimp, and he suggests that the name of QoL impairment should be quimp. He presents convincing argumentation for the use of quimp. Once again, he has developed a concept that is easy to use and the word quimp will probably be rapidly incorporated in the vocabular among persons interested in QoL problems. How is the patient’s quimp?
